Brief: Guerbet Signs New Agreement With IBM Watson Health On AI Solution
Sept 24 (Reuters) - GUERBET SA GRBT.PA :
* SIGNED A NEW AGREEMENT WITH IBM WATSON HEALTH TO
CO-DEVELOP AND
CO-COMMERCIALIZE AN AI SOLUTION
* THIS SECOND AGREEMENT IS AIMED AT DEVELOPING AND MARKETING
A
SOFTWARE SOLUTION TO HELP RADIOLOGISTS AND ONCOLOGISTS DIAGNOSE
AND MONITOR PROSTATE CANCER
Source text for Eikon: ID:nPn3Klycga
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch